Related Experiment Video
Updated: Aug 2, 2026
Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in
1Department of Rheumatology, Peking Union Medical College Hospital, 1 Shuai Fu Yuan, East City, Beijing 100730, China.
Objective:
To investigate the effect of intrathecal injection (i.t.) with methotrexate (MTX) plus dexamethasone (DXM) in treating central nervous system involvement in systemic lupus erythematosus (CNS lupus).
Methods:
Twenty-four CNS lupus patients that were refractory to conventional steroid therapy were selected for i.t. with MTX 10-20 mg plus DXM 10-20 mg. The effects and side effects of i.t. were closely observed.
Results:
The symptoms and signs of 22/24 (91.7%) CNS lupus patients receiving i.t. improved considerably. Cerebrospinal fluid pressure, protein and WBC levels declined from 201.5 +/- 155.4 mm H2O, 145.2 +/- 87.6 mg/dl and 25.1 +/- 14.3/mm3 to 128.7 +/- 108.1 mm H2O, 60.8 +/- 38.3 mg/dl and 6.8 +/- 2.1/mm3 respectively. Transient side effects were observed in 4 patients: 1 with itching sensation of lower limbs, 2 with headache and 1 with incontinence.
Conclusion:
I.t. with MTX plus DXM is a promising method for treating CNS lupus and deserves further investigation.
